Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
Clinical trial NCT07381309 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381309
- Sponsor
- Jun Huang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-02-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.